The right and left heart kinetics of a saccharide-based microbubble ec
ho contrast agent were measured in 11 anesthetized dogs using Doppler
intensity as a measure of microbubble concentration while controlling
for the dose administered, weight of the subject and cardiac output, A
two-phase Doppler time-intensity curve was noted in all vascular regi
ons, A brief first pass effect (phase 1) was found to depend on the co
ntrast dose, cardiac output and subject size, This was followed by a m
uch longer nearly steady-state elevation in the Doppler intensity comp
ared with baseline (phase 2), The kinetics of phase 2 were found to be
the same in all vascular distributions and independent of cardiac out
put. The phase 2 kinetics depend on the contrast dose, subject size an
d elimination characteristics of the contrast agent, The clinically im
portant conclusions are: (1) the magnitude of Doppler enhancement and
duration of the contrast effect can be predicted using the simple form
ulas presented; (2) the flow-dependent portion of the arterial contras
t effect is effectively over only a few seconds after intravenous inje
ction; and (3) the kinetics of phase 2 are the same throughout the bod
y.